Dr. Lal Path Labs Ltd.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomi… Read more
Dr. Lal Path Labs Ltd. (LALPATHLAB) - Total Assets
Latest total assets as of September 2025: ₹29.59 Billion INR
Based on the latest financial reports, Dr. Lal Path Labs Ltd. (LALPATHLAB) holds total assets worth ₹29.59 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dr. Lal Path Labs Ltd. - Total Assets Trend (2011–2025)
This chart illustrates how Dr. Lal Path Labs Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Dr. Lal Path Labs Ltd. - Asset Composition Analysis
Current Asset Composition (March 2025)
Dr. Lal Path Labs Ltd.'s total assets of ₹29.59 Billion consist of 50.2% current assets and 49.8% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹2.69 Billion | 10.8% |
| Accounts Receivable | ₹1.24 Billion | 4.6% |
| Inventory | ₹361.00 Million | 1.3% |
| Property, Plant & Equipment | ₹3.39 Billion | 12.5% |
| Intangible Assets | ₹2.51 Billion | 9.2% |
| Goodwill | ₹5.48 Billion | 20.2% |
Asset Composition Trend (2011–2025)
This chart illustrates how Dr. Lal Path Labs Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dr. Lal Path Labs Ltd.'s current assets represent 50.2% of total assets in 2025, an increase from 25.9% in 2011.
- Cash Position: Cash and equivalents constituted 10.8% of total assets in 2025, up from 2.6% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, an increase from 24.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 20.2% of total assets.
Dr. Lal Path Labs Ltd. Competitors by Total Assets
Key competitors of Dr. Lal Path Labs Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Dr. Lal Path Labs Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Dr. Lal Path Labs Ltd. generates 0.91x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Dr. Lal Path Labs Ltd. generates $ 17.93 in net profit.
Dr. Lal Path Labs Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.51 | 2.87 | 4.11 |
| Quick Ratio | 3.39 | 2.77 | 3.91 |
| Cash Ratio | 1.88 | 1.81 | 0.00 |
| Working Capital | ₹10.86 Billion | ₹ 8.63 Billion | ₹ 7.50 Billion |
Dr. Lal Path Labs Ltd. - Advanced Valuation Insights
This section examines the relationship between Dr. Lal Path Labs Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.82 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 10.6% |
| Total Assets | ₹27.17 Billion |
| Market Capitalization | $1.16 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Dr. Lal Path Labs Ltd.'s assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Dr. Lal Path Labs Ltd.'s assets grew by 10.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Dr. Lal Path Labs Ltd. (2011–2025)
The table below shows the annual total assets of Dr. Lal Path Labs Ltd. from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹27.17 Billion | +10.62% |
| 2024-03-31 | ₹24.56 Billion | +2.95% |
| 2023-03-31 | ₹23.86 Billion | +1.37% |
| 2022-03-31 | ₹23.53 Billion | +41.65% |
| 2021-03-31 | ₹16.61 Billion | +20.89% |
| 2020-03-31 | ₹13.74 Billion | +26.03% |
| 2019-03-31 | ₹10.90 Billion | +18.68% |
| 2018-03-31 | ₹9.19 Billion | +20.25% |
| 2017-03-31 | ₹7.64 Billion | +22.22% |
| 2016-03-31 | ₹6.25 Billion | +31.54% |
| 2015-03-31 | ₹4.75 Billion | +35.22% |
| 2014-03-31 | ₹3.52 Billion | +30.67% |
| 2013-03-31 | ₹2.69 Billion | +51.95% |
| 2012-03-31 | ₹1.77 Billion | +4.36% |
| 2011-03-31 | ₹1.70 Billion | -- |